Project Grant R21HD114297

Award Date 7/17/24
Completion Date 6/30/26
Dollars Obligated $273K
Federal Grant Program
93.865
Assistance Type
Project Grant
Place of Performance
Washington, DC 20010, USA
Similar Awards
This $161,500 federal Project Grant was awarded by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The funding will support research to understand the molecular mechanisms underlying the genetic causes of heterotaxy, a severe form of congenital heart disease (CHD) that affects organ left-right asymmetry. The 2-year project, awarded to the Rector & Visitors of the University of...
This $668,211 Project Grant award from the National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research) supports research at the University of Maryland, Baltimore to investigate the role of dysregulated RNA metabolism in maternal diabetes-induced neural tube defects (NTDs). The key research objectives are to: 1) Determine if the repression of miR-322 by maternal diabetes contributes to neuroepithelial cell dysfunction and NTD...
This federal Project Grant awarded by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) provides $164,992 to the University of California, Davis to conduct research on the cellular impacts of CHD8 haploinsufficiency and characterize microglial activity in CHD8 mutant mice. The research aims to elucidate the cell-specific transcriptomic mechanisms associated with CHD8 haploinsufficiency and...
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $610,784 to Emory University to comprehensively assess the impact of 22q11.2 Deletion Syndrome (22QDS) on microglial function. The project aims to determine the molecular and cellular impacts of 22q11.2 deletions on microglia, assess the role of miRNA dysregulation in 22QDS microglia, and evaluate the effects of 22QDS microglia on neuronal...
This federal Project Grant award, valued at $249,000.00 and awarded by the National Institute of Child Health and Human Development under the Child Health and Human Development Extramural Research program (CFDA 93.865), supports research to identify new therapeutics and elucidate molecular mechanisms underlying congenital disorders of glycosylation (CDGs). The key objectives of this 3-year award are to: 1) determine the mechanisms of modifier genes that can rescue a model of DPAGT1-CDG, a rare...
This federal Project Grant award from the National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research) provides $267,000 in funding to Boston Children's Hospital to conduct research on the role of microRNA dysregulation in the pathogenesis of Sudden Infant Death Syndrome (SIDS). The research project aims to investigate two specific microRNAs, miR-34a-5p and miR-122-5p, and their mRNA targets HCN3 and CPEB1, which are implicated...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), is funding research to investigate the role of retrotransposable elements (RTEs) in neurodevelopment and neurodevelopmental disorders. The $364,324 award, with a project period from August 15, 2024 to February 28, 2026, will support two specific aims. The first aim is to test the impact of RTE expression and...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), provides $164,990.00 to The General Hospital Corporation (doing business as Massachusetts General Hospital) for a research project investigating the role of the ZFHX4 gene in lung mesenchyme development. The key objectives of this 2-year project are to: 1) Investigate the dynamics of ZFHX4 binding, chromatin...
This federal Project Grant award from the National Institute of Child Health and Human Development (NICHD) under CFDA Program 93.865 Child Health and Human Development Extramural Research will provide $160,000 to support research on the role of the RERE and SPEN genes in the development of congenital heart defects associated with 1p36 deletion syndrome. The research aims to elucidate the morphogenetic and molecular mechanisms by which RERE and SPEN function during cardiac development. Specific...
This federal Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), provides $429,000.00 to the Regents of the University of Michigan to conduct research on the molecular mechanisms underlying changes in inhibitory synapses in Down syndrome. The primary goal is to discover how the overexpression of the Down Syndrome Cell Adhesion Molecule (DSCAM) gene, resulting from...

This federal Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), provides $273,000.00 in funding to the Children's Research Institute to investigate the role of miRNA-mediated buffering mechanisms in driving phenotypic variability in 22q11.2 deletion syndrome.

The key objectives are to establish how retinoic acid (RA) buffering is disrupted in 22q11.2 deletion syndrome, and determine if reduced miRNA processing due to DGCR8 haploinsufficiency contributes to altered RA buffering and congenital heart defects. This research aims to provide a novel understanding of the gene-environment interaction mechanisms underlying structural birth defects associated with 22q11.2 deletion syndrome, with the goal of informing potential prevention strategies.

Generated 5/13/25, 1:44 AM